MOLECULAR-CLONING OF THE CANINE ANGIOTENSIN-II RECEPTOR - AN AT1-LIKE RECEPTOR WITH REDUCED AFFINITY FOR DUP753

被引:31
作者
BURNS, L
CLARK, KL
BRADLEY, J
ROBERTSON, MJ
CLARK, AJL
机构
[1] UNIV LONDON ST BARTHOLOMEWS HOSP & MED COLL,DEPT CHEM ENDOCRINOL,LONDON EC1A 7BE,ENGLAND
[2] GLAXO GRP RES LTD,DEPT CARDIOVASC & RESP PHARMACOL,WARE SG12 0DP,HERTS,ENGLAND
关键词
ANGIOTENSIN RECEPTOR; NONPEPTIDE ANTAGONISTS; CDNA CLONING; DOG AORTA; VASCULAR CONTRACTILITY; COS CELL;
D O I
10.1016/0014-5793(94)80307-2
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Canine aortic strip studies revealed insensitivity of angiotensin II (AII)-induced aortic contraction to inhibition by the non-peptide antagonist DuP753 (pK(B) = 6.7 +/- 0.1). In order to determine the origin of this phenomenon we cloned the canine homologue of the AT(1) AII receptor. Expression of this cDNA in COS-7 cells indicated a low affinity of DuP753 for the cloned receptor (K-D = 92 nM). The predicted amino acid sequence is highly homologous to other mammalian AT(1) receptors; sequence comparisons suggest the pharmacological difference may be the result of a threonine residue in position 163 in the IVth transmembrane domain.
引用
收藏
页码:146 / 150
页数:5
相关论文
共 16 条
  • [1] THE MAS ONCOGENE ENHANCES ANGIOTENSIN-INDUCED [CA-2+]I RESPONSES IN CELLS WITH PREEXISTING ANGIOTENSIN-II RECEPTORS
    AMBROZ, C
    CLARK, AJL
    CATT, KJ
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA, 1991, 1133 (01) : 107 - 111
  • [2] SOME QUANTITATIVE USES OF DRUG ANTAGONISTS
    ARUNLAKSHANA, O
    SCHILD, HO
    [J]. BRITISH JOURNAL OF PHARMACOLOGY AND CHEMOTHERAPY, 1959, 14 (01): : 48 - 58
  • [3] BALA T, 1991, MOL PHARMACOL, V40, P401
  • [4] CLONING AND CHARACTERIZATION OF A HUMAN ANGIOTENSIN-II TYPE-1 RECEPTOR
    BERGSMA, DJ
    ELLIS, C
    KUMAR, C
    NUTHULAGANTI, P
    KERSTEN, H
    ELSHOURBAGY, N
    GRIFFIN, E
    STADEL, JM
    AIYAR, N
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1992, 183 (03) : 989 - 995
  • [5] NOMENCLATURE FOR ANGIOTENSIN RECEPTORS - A REPORT OF THE NOMENCLATURE-COMMITTEE OF THE COUNCIL-FOR-HIGH-BLOOD-PRESSURE-RESEARCH
    BUMPUS, FM
    CATT, KJ
    CHIU, AT
    DEGASPARO, M
    GOODFRIEND, T
    HUSAIN, A
    PEACH, MJ
    TAYLOR, DG
    TIMMERMANS, PBMWM
    [J]. HYPERTENSION, 1991, 17 (05) : 720 - 721
  • [6] A TECHNIQUE FOR RADIOLABELING DNA RESTRICTION ENDONUCLEASE FRAGMENTS TO HIGH SPECIFIC ACTIVITY
    FEINBERG, AP
    VOGELSTEIN, B
    [J]. ANALYTICAL BIOCHEMISTRY, 1983, 132 (01) : 6 - 13
  • [7] LIPOFECTION - A HIGHLY EFFICIENT, LIPID-MEDIATED DNA-TRANSFECTION PROCEDURE
    FELGNER, PL
    GADEK, TR
    HOLM, M
    ROMAN, R
    CHAN, HW
    WENZ, M
    NORTHROP, JP
    RINGOLD, GM
    DANIELSEN, M
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1987, 84 (21) : 7413 - 7417
  • [8] POSSIBLE IMPLICATION OF PEPTIDASE ACTIVITY IN DIFFERENT POTENCY OF ANGIOTENSIN-II AND ANGIOTENSIN-III FOR DISPLACING [I-125] ANGIOTENSIN-II BINDING IN PIG AORTA
    FUJIMOTO, M
    MIHARA, S
    SHIGERI, Y
    ITAZAKI, K
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 1992, 215 (2-3) : 259 - 264
  • [9] MOLECULAR-CLONING AND CHARACTERIZATION OF THE ANGIOTENSIN RECEPTOR SUBTYPE IN PORCINE AORTIC SMOOTH-MUSCLE
    ITAZAKI, K
    SHIGERI, Y
    FUJIMOTO, M
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY-MOLECULAR PHARMACOLOGY SECTION, 1993, 245 (02): : 147 - 156
  • [10] LIGAND - A VERSATILE COMPUTERIZED APPROACH FOR CHARACTERIZATION OF LIGAND-BINDING SYSTEMS
    MUNSON, PJ
    RODBARD, D
    [J]. ANALYTICAL BIOCHEMISTRY, 1980, 107 (01) : 220 - 239